A detailed history of Cape Ann Savings Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Cape Ann Savings Bank holds 4,013 shares of ABBV stock, worth $784,059. This represents 0.43% of its overall portfolio holdings.

Number of Shares
4,013
Previous 8,706 53.91%
Holding current value
$784,059
Previous $1.59 Million 56.59%
% of portfolio
0.43%
Previous 1.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$154.79 - $180.76 $726,429 - $848,306
-4,693 Reduced 53.91%
4,013 $688,000
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $598,845 - $682,328
-3,747 Reduced 30.09%
8,706 $1.59 Million
Q4 2023

Mar 15, 2024

SELL
$137.6 - $154.97 $5,504 - $6,198
-40 Reduced 0.32%
12,453 $1.93 Million
Q3 2023

Oct 25, 2023

SELL
$133.59 - $154.65 $18,702 - $21,651
-140 Reduced 1.11%
12,493 $1.86 Million
Q2 2023

Sep 18, 2023

BUY
$132.51 - $164.9 $39,620 - $49,305
299 Added 2.42%
12,633 $1.7 Million
Q1 2023

Sep 18, 2023

SELL
$144.61 - $166.54 $32,103 - $36,971
-222 Reduced 1.77%
12,334 $1.97 Million
Q4 2022

Sep 18, 2023

SELL
$138.31 - $165.87 $53,387 - $64,025
-386 Reduced 3.06%
12,247 $1.98 Million
Q3 2022

Sep 18, 2023

BUY
$134.21 - $153.93 $30,331 - $34,788
226 Added 1.83%
12,556 $1.69 Million
Q2 2022

Aug 24, 2022

BUY
$137.62 - $174.96 $44,451 - $56,512
323 Added 2.69%
12,330 $1.89 Million
Q1 2022

May 18, 2022

SELL
$131.98 - $163.75 $410,457 - $509,262
-3,110 Reduced 20.57%
12,007 $1.95 Million
Q4 2021

Feb 16, 2022

BUY
$107.43 - $135.93 $369,344 - $467,327
3,438 Added 29.44%
15,117 $2.05 Million
Q3 2021

Nov 22, 2021

BUY
$106.4 - $120.78 $387,721 - $440,122
3,644 Added 45.35%
11,679 $1.26 Million
Q2 2021

Aug 17, 2021

BUY
$105.21 - $117.21 $49,764 - $55,440
473 Added 6.25%
8,035 $905,000
Q1 2021

May 25, 2021

SELL
$102.3 - $112.62 $3,069 - $3,378
-30 Reduced 0.4%
7,562 $818,000
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $88,780 - $119,863
-1,103 Reduced 12.69%
7,592 $813,000
Q2 2020

Aug 11, 2020

BUY
$73.37 - $98.18 $146,666 - $196,261
1,999 Added 29.85%
8,695 $854,000
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $69,592 - $83,670
-1,105 Reduced 14.16%
6,696 $507,000
Q2 2019

Jul 31, 2019

SELL
$65.7 - $83.98 $7,818 - $9,993
-119 Reduced 1.5%
7,801 $568,000
Q4 2018

Feb 15, 2019

SELL
$77.85 - $96.01 $41,260 - $50,885
-530 Reduced 6.27%
7,920 $730,000
Q3 2018

Oct 22, 2018

BUY
$88.91 - $98.84 $751,289 - $835,198
8,450 New
8,450 $760,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $345B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cape Ann Savings Bank Portfolio

Follow Cape Ann Savings Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cape Ann Savings Bank, based on Form 13F filings with the SEC.

News

Stay updated on Cape Ann Savings Bank with notifications on news.